HSIL Limited [HSIL] vs Fischer Medical [FISCHER] Detailed Stock Comparison

HSIL Limited

NSE
Loading...

Fischer Medical Ventures Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: HSIL Limited wins in 9 metrics, Fischer Medical Ventures Ltd. wins in 2 metrics, with 0 ties. HSIL Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric HSIL Limited Fischer Medical Ventures Ltd. Better
P/E Ratio (TTM) 18.70 63.39 HSIL Limited
Price-to-Book Ratio N/A 6.72 N/A
Debt-to-Equity Ratio 89.90 10.26 Fischer Medical Ventures Ltd.
PEG Ratio N/A 0.13 N/A
EV/EBITDA 20.08 57.80 HSIL Limited
Profit Margin (TTM) 72.43% 15.17% HSIL Limited
Operating Margin (TTM) N/A 20.57% N/A
EBITDA Margin (TTM) N/A 20.57% N/A
Return on Equity 1,493.74% 0.36% HSIL Limited
Return on Assets (TTM) 7.66% 0.26% HSIL Limited
Free Cash Flow (TTM) N/A $-927.26M N/A
1-Year Return -22.20% -57.40% HSIL Limited
Price-to-Sales Ratio (TTM) 3.75 9.41 HSIL Limited
Enterprise Value $64.93B $24.93B HSIL Limited
EV/Revenue Ratio 4.54 9.59 HSIL Limited
Gross Profit Margin (TTM) -49.38% 50.38% Fischer Medical Ventures Ltd.
Revenue per Share (TTM) N/A $3 N/A
Earnings per Share (Diluted) N/A $0.59 N/A
Beta (Stock Volatility) N/A -0.03 N/A

HSIL Limited vs Fischer Medical Ventures Ltd. Stock Performance Analysis

Loading Price Chart...

HSIL
FISCHER

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
HSIL Limited4.53%7.81%9.94%19.48%-10.96%-14.17%
Fischer Medical Ventures Ltd.-1.55%10.75%2.12%7.06%-21.38%-14.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
HSIL Limited-22.20%6.42%200.14%806.19%1,225.70%2,328.54%
Fischer Medical Ventures Ltd.-57.40%-70.45%1,348.00%-12.14%101.56%439.49%

Performance & Financial Health Analysis: HSIL Limited vs Fischer Medical Ventures Ltd.

MetricHSILFISCHER
Market Information
Market Cap i₹53.70B₹24.43B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i57,77671,158
90 Day Avg. Volume i89,766126,154
Last Close₹645.75₹35.64
52 Week Range₹465.00 - ₹1,009.00₹31.13 - ₹124.20
% from 52W High-36.00%-71.30%
All-Time High₹1,307.90 (Dec 16, 2024)₹2,386.00 (Apr 21, 2008)
% from All-Time High-50.63%-98.51%
Growth Metrics
Quarterly Revenue Growth-1.27%7.61%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i0.72%0.15%
Operating Margin (TTM) iN/A0.21%
Return on Equity (TTM) i14.94%0.00%
Debt to Equity (MRQ) i89.9010.26
Cash & Liquidity
Book Value per Share (MRQ)N/A₹5.57
Cash per Share (MRQ)N/A₹0.67
Operating Cash Flow (TTM) i₹686.00M₹-1,015,668,000
Levered Free Cash Flow (TTM) i₹1.93B₹12.08M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: HSIL Limited vs Fischer Medical Ventures Ltd.

MetricHSIL (Jun 15, 2025)FISCHER (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.7063.39
Forward P/E i15.71N/A
PEG Ratio iN/A0.13
Price to Sales (TTM) i3.759.41
Price to Book (MRQ) iN/A6.72
Market Capitalization
Market Capitalization i₹53.70B₹24.43B
Enterprise Value i₹64.93B₹24.93B
Enterprise Value Metrics
Enterprise to Revenue i4.549.59
Enterprise to EBITDA i20.0857.80
Risk & Other Metrics
Beta iN/A-0.03
Book Value per Share (MRQ) iN/A₹5.57

Financial Statements Comparison: HSIL Limited vs Fischer Medical Ventures Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHSILFISCHER (2025)
Revenue/Sales iN/A1.11B
Cost of Goods Sold iN/A915.90M
COGS % of Revenue i-82.7%
Gross Profit iN/A191.09M
Gross Margin i-17.3%
Research & Development iN/AN/A
Operating Income (EBIT) iN/A30.61M
Operating Margin i-2.8%
EBITDA iN/A53.47M
EBITDA Margin i-4.8%
Pre-Tax Income iN/A22.23M
Pre-Tax Income % of Revenue i-2.0%
Income Tax iN/A10.15M
Income Tax % of Revenue i-0.9%
Net Income (Profit) iN/A12.08M
Profit Margin i-1.1%

Balance Sheet & Liquidity Metrics

MetricHSILFISCHER (2025)
Cash & Equivalents iN/A1.04B
Total Current Assets iN/A3.65B
Total Current Assets % of Revenue i-330.0%
Total Current Liabilities iN/A1.02B
Total Current Liabilities % of Revenue i-92.0%
Long-Term Debt iN/A172.06M
Long-Term Debt % of Revenue i-15.5%
Total Shareholders Equity iN/A3.38B
Retained Earnings iN/A29.05M
Retained Earnings % of Revenue i-2.6%
Property, Plant & Equipment iN/A89.03M

Cash Flow Statement Comparison

MetricHSILFISCHER (2025)
Operating Cash Flow iN/A-1.02B
Operating Cash Flow % of Revenue i--91.8%
Capital Expenditures iN/A-59.87M
Free Cash Flow iN/A-927.26M
FCF Margin i--83.8%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricHSILFISCHER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i64.70M654.52M
Float Shares iN/A164.93M
% Held by Insiders iN/A76.28%
% Held by Institutions iN/A2.54%
% Held by Public iN/A21.18%

Dividend Analysis & Yield Comparison: HSIL Limited vs Fischer Medical Ventures Ltd.

MetricHSILFISCHER
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A